PhRMA: Need For Long-Term Japan Pharma Policies
This article was originally published in The Pink Sheet Daily
Executive Summary
The U.S. industry association PhRMA continues to see substantial progress with regulatory and health care reforms in Japan but stresses the remaining need for long-term policies that encourage innovation, foreign investment and the broader use of modern vaccines.